1. Home
  2. BRCC vs TLSA Comparison

BRCC vs TLSA Comparison

Compare BRCC & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BRC Inc.

BRCC

BRC Inc.

HOLD

Current Price

$1.21

Market Cap

152.1M

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.30

Market Cap

155.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRCC
TLSA
Founded
2014
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.1M
155.3M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
BRCC
TLSA
Price
$1.21
$1.30
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$2.25
N/A
AVG Volume (30 Days)
943.7K
202.8K
Earning Date
05-04-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$398,263,000.00
N/A
Revenue This Year
$9.68
N/A
Revenue Next Year
$9.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.73
N/A
52 Week Low
$0.60
$1.04
52 Week High
$2.10
$2.60

Technical Indicators

Market Signals
Indicator
BRCC
TLSA
Relative Strength Index (RSI) 45.93 55.80
Support Level $1.18 $1.26
Resistance Level $1.39 $1.44
Average True Range (ATR) 0.09 0.09
MACD -0.02 0.02
Stochastic Oscillator 49.86 92.86

Price Performance

Historical Comparison
BRCC
TLSA

About BRCC BRC Inc.

BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: